|
Volumn 56, Issue 1, 2008, Pages 175-177
|
Statins for the primary prevention of cardiovascular events in elderly patients: A picture from clinical practice without strong evidence from clinical trials [8]
a b c d b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVINOLIN;
PRAVASTATIN;
ROSUVASTATIN;
SIMVASTATIN;
AGED;
CARDIOVASCULAR DISEASE;
CLINICAL DECISION MAKING;
CLINICAL PRACTICE;
ELDERLY CARE;
EVIDENCE BASED PRACTICE;
FEMALE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
OUTCOMES RESEARCH;
PRIMARY PREVENTION;
SECONDARY PREVENTION;
AGED;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS AS TOPIC;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INCIDENCE;
PRIMARY PREVENTION;
UNITED STATES;
|
EID: 37749042744
PISSN: 00028614
EISSN: 15325415
Source Type: Journal
DOI: 10.1111/j.1532-5415.2007.01486.x Document Type: Letter |
Times cited : (12)
|
References (10)
|